Authors: Schmiegelow, K Nyvold, C Seyfarth, J Pieters, R Rottier, MMA Knabe, N Ryder, LP Madsen, HO Svejgaard, A Kaspers, GJL

Citation: K. Schmiegelow et al., Post-induction residual leukemia in childhood acute lymphoblastic leukemiaquantified by PCR correlates with in vitro prednisolone resistance, LEUKEMIA, 15(7), 2001, pp. 1066-1071

Authors: Kearns, PR Pieters, R Rottier, MMA Pearson, ADJ Hall, AG

Citation: Pr. Kearns et al., Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia, BLOOD, 97(2), 2001, pp. 393-398

Authors: Haarman, EG Kaspers, GJL Pieters, R Rottier, MMA Veerman, AJP

Citation: Eg. Haarman et al., Modulation of glucocorticoid resistance in childhood acute lymphoblastic leukemia; Preliminary results, HEMAT BLOOD, 40, 2001, pp. 236-243

Authors: de Haas, TGKJ Zwaan, CM Wondergem, MJ Pieters, R Kaspers, GJL Loonen, AH Rottier, MMA Wunsche, R Creutzig, U Bartl, S Hahlen, K Broxterman, HJ Ossenkoppele, GJ Veerman, AJP

Citation: Tgkj. De Haas et al., In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children, HEMAT BLOOD, 40, 2001, pp. 244-250

Authors: Zwaan, CM Kaspers, GJL Pieters, R Ramakers-Van Woerden, NL den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP

Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2779-2786

Authors: Zwaan, CM Kaspers, GJL Pieters, R Woerden, NLR den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP

Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2879-2886